Business
Investor Event and Presentation
Aptamer Group PLC will present at the ShareSoc Growth Company Seminar on October 8, 2025, in Leeds. The event starts with registration at 4:30 pm and presentations commencing at 5:00 pm. The presentation will be delivered by the Chief Executive Officer and the Chief Financial Officer, offering investors insights into the company's recent progress. A link to the presentation will be available on the company website following the event. The company operates in the US$210 billion market for antibody alternatives. No new material information will be disclosed at this event. Disclaimer*
About this update from Aptamer Group Plc
[{"type":"text","content":"\n\n \n \n26 September 2025\n \nAptamer Group plc\n \n(\"Aptamer\", the \"Company\" or the \"Group\")\n \nInvestor Event and Presentation\n \nAptamer Group plc (AIM: APTA), the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that the Company will be presenting at the ShareSoc Growth Company Seminar on Wednesday, 8 October 2025, at the Leonardo Hotel, Brewery Place, Leeds, LS10 1NE. Event registration opens at 4.30 pm and presentations commence at 5.00 pm.\n \nDr Arron Tolley, Chief Executive Officer, and Andrew Rapson, Chief Financial Officer, will deliver a presentation, offering investors the opportunity to engage directly with the Company and gain valuable insights into its recent progress.\n \nFor further information on the ShareSoc Growth Company Seminar and registration, please visit the event website: https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-person-event-leeds/\n \nA link to Aptamer's presentation will be made available on the Company website following the event.\n \nNo new material information will be disclosed at this event.\n \n- Ends -\n \nFor further information, please contact: \n \n\n\n\n\nAptamer Group plc \nDr Arron Tolley, Chief Executive Officer\n\n\n+44 (0) 1904 217 404 \n\n\n\n\nSPARK Advisory Partners Limited - Nominated Adviser \nAndrew Emmott / Jade Bayat \n\n\n+44 (0) 20 3368 3550 \n\n\n\n\nTurner Pope Investments (TPI) Limited - Broker \nJames Pope / Andrew Thacker \n\n\n+44 (0) 20 3657 0050 \n\n\n\n\nNorthstar Communications Limited - Investor Relations\nSarah Hollins \n\n\n+44 (0) 113 730 3896\n\n\n\n\n \nAbout Aptamer Group\n \nAptamer Group is a leading developer of next-generation synthetic binders delivering innovation to the life sciences industry. The Group develops Optimer® binders, advanced molecules that work like antibodies by attaching to specific targets in the body. These binders are used in medicine, diagnostic tests, and research tools, offering benefits like high stability, reliable performance, and lower costs compared to traditional antibodies.\n \nAptamer operates a fee-for-service business in the US$210 billion market for antibody alternatives, work...